Year: 2020
Type: review
Abstract: A diverse panel of pediatric cancer advocates and experts, whose collective experience spans the continuum of international academic medicine, industry, government research, and cancer advocacy, recently discussed challenges for pediatric cancer research in the context of coronavirus disease 2019 (COVID-19). Specifically, this special report addresses the following focus areas: (a) the critical role that translational research has played in transforming pediatric cancer outcomes; (b) the current and potential future impact of COVID-19 on pediatric cancer research; (c) target areas of COVID-19 research that may have application in immunity, oncogenesis, and therapeutic discovery; and (d) future considerations and directions in maintaining pediatric cancer research during and after COVID-19.
Source: Pediatric Blood & Cancer
DOI: 10.1002/pbc.28435
Institutions: Nationwide Children's Hospital, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Sanofi (United States), National Institute for Health and Care Research, European Society for Paediatric Oncology, Cancer Research UK Clinical Trials Unit, NIHR Birmingham Biomedical Research Centre, Solving Kids' Cancer, Bristol-Myers Squibb (United States), London Cancer, National Cancer Institute, Center for Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Cancer Research UK
Award: G7179533931
OpenAlex ID: W3036028454